Discovery of PF-07220060, a potent and selective CDK4 inhibitor

被引：1
作者：
Anders, Lars
Gallego, Gary
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-ND12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ND12
引用
收藏
页数：2
相关论文
共 50 条
[41]   PALBOCICLIB Cyclin CDK4/CDK6 Inhibitor Oncolytic [J].
Haddley, K. .
DRUGS OF THE FUTURE, 2013, 38 (11) :745-755
[42]   The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib [J].
Gong Xueqian ;
Chio, Li-Chun ;
Webster, Yue ;
Lallena, Maria Jose ;
Boehnke, Karsten ;
Torres, Raquel ;
Iversen, Phil ;
De Dios, Alfonso ;
Smith, Ian ;
Reinhard, Christoph ;
Peng, Sheng-Bin ;
Dempsey, Jack ;
Burke, Teresa ;
Chen, Shih-Hsun ;
Stewart, Trent ;
Beckmann, Richard ;
Wu, Wenjuan ;
Buchanan, Sean G. .
MOLECULAR CANCER RESEARCH, 2016, 14
[43]   Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer [J].
Freeman-Cook, Kevin D. ;
Hoffman, Robert L. ;
Behenna, Douglas C. ;
Boras, Britton ;
Carelli, Jordan ;
Diehl, Wade ;
Ferre, Rose Ann ;
He, You-Ai ;
Hui, Andrea ;
Huang, Buwen ;
Huser, Nanni ;
Jones, Rhys ;
Kephart, Susan E. ;
Lapek, John ;
McTigue, Michele ;
Miller, Nichol ;
Murray, Brion W. ;
Nagata, Asako ;
Nguyen, Lisa ;
Niessen, Sherry ;
Ninkovic, Sacha ;
O'Doherty, Inish ;
Ornelas, Martha A. ;
Solowiej, James ;
Sutton, Scott C. ;
Tran, Khanh ;
Tseng, Elaine ;
Visswanathan, Ravi ;
Xu, Meirong ;
Zehnder, Luke ;
Zhang, Qin ;
Zhang, Cathy ;
Dann, Stephen .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) :9056-9077
[44]   Discovery of CDK4 inhibitors by convolutional neural networks [J].
Xu, Yinqiu ;
Chen, Pingping ;
Lin, Xinhao ;
Yao, Hequan ;
Lin, Kejiang .
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (03) :165-177
[45]   The CDK4/6 inhibitor has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma [J].
Ku, Bo Mi ;
Koh, Jiae ;
Bae, Yeon-Hee ;
Sun, Jong-Mu ;
Lee, Se-hoon ;
Ahn, Jin Seok ;
Park, Keunchil ;
Ahn, Myung-Ju .
CANCER RESEARCH, 2016, 76
[46]   Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs [J].
Green, Jennifer L. ;
Okerberg, Eric S. ;
Sejd, Josilyn ;
Palafox, Marta ;
Monserrat, Laia ;
Alemayehu, Senait ;
Wu, Jiangyue ;
Sykes, Maria ;
Aban, Arwin ;
Serra, Violeta ;
Nomanbhoy, Tyzoon .
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) :771-779
[47]   Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer [J].
Xu, Congjun ;
Xiao, Zhanghong ;
Wang, Jing ;
Lai, Hualu ;
Zhang, Tao ;
Guan, Zilin ;
Xia, Meng ;
Chen, Meixu ;
Ren, Lingling ;
He, Yuanfeng ;
Gao, Yuqi ;
Zhao, Chunshun .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) :13312-13326
[48]   Improving immunotherapy with a combination of CDK4/6 inhibitor [J].
Yoshida, A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) :S208-S208
[49]   Factors influencing CDK4/6 inhibitor adherence [J].
Clement, Navya ;
Stutsky, Martha ;
Gurubaran, Shreevidya Periyasamy Shanmugavel ;
Smullen, Kate ;
Argeros, Andrew ;
Wolfe, Diane ;
Donovan, Jennifer .
CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 :24-24
[50]   CDK4/6 inhibitor resistance: A bibliometric analysis [J].
Pang, Jiayuecheng ;
Li, Hengyu ;
Sheng, Yuan .
FRONTIERS IN ONCOLOGY, 2022, 12
12345